Sweet Biopharma Day‘s 3rd Edition | Québec, Canada
Call for startup proposals, now open
We are pleased to announce that the 3rd edition of Sweet Biopharma Day will be held, in person, on April 12, 2023. This unique, by invitation-only event invites young Canadian biotechs to submit an application for a chance to present in front of key global biopharma companies, as well as leading Canadian life sciences ecosystem’s stakeholders (such as venture capitalists and representatives from governments and associations). The intent is to develop potential collaborations or partnerships.
Are you a biotechnology start-up or company with fewer than 25 employees and focused on innovative research and development? Do you have a strong commercial potential? You can apply for the chance to be among the 16 promising Canadian biotech companies, the “Sweet 16”, who will be invited to present in front of key biopharmaceutical industry stakeholders on April 12th.
How to apply: Companies must provide a 2-page executive summary and a short presentation (one set of no more than 5 slides) describing their cutting-edge technology, target indications, and points of differentiation. Application packages must be submitted via this form no later than Wednesday, March 8, 2023, at 11:59 p.m. EDT.
CQDM completed its series of three Webinars:
The Evolving Landscape of AI Implementation in New Drug Discovery & Development!
We are extremely grateful to Philip Tagari, VP of Research (Therapeutic Discovery) at Amgen for chairing the Webinars. We also wish to thank all of our speakers and panelists!
Where to watch the webinars?
Click on the following links:
Using Machine Learning on Publicly Available Biomedical Data for Target Discover
Generation of Innovative Therapeutics using Artificial Intelligence
From Candidates to Drugs – Applications of Artificial Intelligence in Translational Research
Do you have any topic to suggest for the next series?
Write us your ideas at: firstname.lastname@example.org